drugset / Trial / NCT00086970

Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors

NCT00086970

Phase 1 Terminated 32 enrolled National Cancer Institute (NCI)
RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized phase I trial is studying the side effects and best dose of O(6)-benzylguanine when given together with ifosfamide and to see how well it works compared to ifosfamide alone in treating patients with unresectable metastatic solid tumors. Drugs used in chemotherapy, such as ifosfamide and O(6)-benzylguanine, work in different ways to stop tumor cells from dividing so they stop growing or die. Combining ifosfamide with O(6)-benzylguanine may kill more tumor cells

Timeline

Start
2004-06
Primary completion
2005-11
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Ifosfamide Small molecule Intravenous
Subject O6-benzylguanine Small molecule Intravenous